2012 Presentation

International Symposium on Natural Products Chemistry and Chemical Biology 2012

Nov. 23-26, 2012, Hangzhou, China
  • Osada H.
    Integrative approach for target identification of bioactive compounds

24th EORTC-NCI-AACR: Symposium on Molecular Targets and Cancer Therapeutics

Nov. 6th-9th, 2012, Dublin, Ireland
  • Watanabe N, Ooi LC, Osada H
    High-Throughput screening to identify small molecule inhibitors of PK27Kip1 Ubiquitination

GRDC Symposium 2012

Nov. 2012, Seoul, Korea
  • Osada H.
    Target identification of bioactive small molecules
  • Asam Y, Jang JH, Soung NK, He L, JW, Oh H, Muroi M, Osada H, kim BY, Ahn JS
    Protuboxepin A, a marine fungal metabolite, inducing metapase arrest and chromosomal misalignment in tumor cells

The 1st International Symposium on Chemical Biology of Natural Products:
Target ID and Regulation of Bioactivity

Oct. 31st - Nov. 1st, 2012, Kyoto, Japan
  • Muroi M., Osada H.
    Proteome-based profiling approach to predict targets of bioactive small molecules using two-dimensional fluorescence differential gel electrophoresis (2D-DIGE)

Queenstown Molecular Biology Meeting (QMB) Chemical Biology and Drug Discovery

Aug. 27th - 29th, 2012, Queenstown, New Zealand
  • Osada H.
    Multi-dimensional profiling for the target identification of bioactive small molecules

13th International Conference on Systems Biology (ICSB 2012)

Aug. 19th - 23rd, 2012, University of Toronto, Toronto, Canada
  • Osada H.
    Systems chemical biology for drug discovery from microbial metabolites.

International Symposium on Natural Products Biosynthesis 8th US-Japan Seminar: Enzymology, Structural Biology, Drug Discovery, Genome Mining

June 17th - 22nd, 2012, Awaji Yumebutai, Hyogo, Japan.
  • Osada H.
    Comprehensive analyses of biosynthesis and biological activity of reveromycin A
  • Kato N., Okumura H., Suzuki H., Takahashi S., and Osada H.
    A point mutation in ftmD inactivates the fumitremorgin biosynthetic pathway in Aspergillus fumigatus Af293
  • Takahashi S., Panthee S., and Osada H.
    Novel compound which up-regulates secondary metabolite gene cluster

2nd RIKEN-SNU Symposium on Chemistry and Biology

May 17th - 18th, 2012, Nami Island, Chuncheon, Korea
  • Osada H.
    Integrative research of chemistry and biology on Reveromycin A
  • Ito A., Hirohama M., Igarashi Y., Kondoh Y., Saito T., Osada H., and Yoshida M.
    Spectomycin B1 suppresses Estrogen Receptor α-Dependent Breast Cancer Cell Growth by inhibiting a SUMO E2 Activity
  • Sakata K., Yamamoto Y., Kondoh Y., Saito T., Osada H., and Kojima S.
    Screening of Chemical Regulators for TGF-β Activation Reaction

Seminar at KRIBB

May, 2012, Ochang, Korea
  • Osada H.
    Novel methods for drug discovery

RIKEN-MaxPlanck Joint Research Center Kick Off Sympojium

Mar. 6th - 7th, 2012, Dortmund, Germany
  • Saito T., and Osada H.
    Research support provided by RIKEN Natural Products Depository (NPDepo) and collaborative research with RIKEN NPDepo
  • Kojima S., Sakata K., Yamamoto Y., Honda K., Kondoh Y., Saito T., and Osada H.
    Screening of novel regulators targeting TGF-β activation reaction
  • Tatsukawa H., Honda K., Kondoh Y., Dohmae N., Ishibashi N., Osada H., and Kojima S.
    Trials to identify a target molecule of acyclic retinoid, suppressing recurrence of hepatocellular carcinoma
  • Boone C. M., Piotrowski J. S., Deshpande R., Claire S., Andrusiak K., Saito T., Nislow C., Osada H., Myers C., and Yoshida M.
    Linking novel bioactive compounds to their targets and pathways using high-throughput yeast chemical genomics
  • Piotrowski J. S., Deshpande R., Andrusiak K., Saito T., Osada H., Myers C., Yoshida M., and Boone C. M.
    Linking novel bioactive compounds to their targets and pathways using high-throughput yeast chemical genomics
  • Ito A., Hirohama M., Igarashi Y., Kondoh Y., Saito T., Osada H., and Yoshida M.
    Discovery of spectomycin B1 as a SUMO E2 inhibitor and its potential for anti-breast cancer therapy

6th Korea-Japan Chemical Biology Symposium

Jan. 26th - 28th, 2012, Sapporo,
  • Takahashi S., Kumano T., and Osada H.
    Exquisite control of Spiroacetal Formation in reveromycin A biosynthesis
  • Osada H., and Nogawa T.
    Passion for bioactive compounds
  • Asami Y., Jang J., Jang J., Kim B., Osada H., and Ahn J.
    Fusarisetin A, a novel cancer cell motility inhibitor from a soil fungus, Fusarium sp. FN080326
  • Sasazawa Y., Kanagaki S., Tashiro E., Nogawa T., Muroi M., Kondoh Y., Osada H., and Imoto M.
    Xanthohumol impairs autophagosome maturation through direct inhibition of Valosin-Containing protein
  • Kawatani M., Muroi M., and Osada H.
    Target identification of Cytotoxic compounds based on the proteomic profiling by 2D-DIGE
  • Ueki M., Morita N., Koshiro N., Uramoto M., and Osada H.
    Exploring for the production potential of microbial metabolites
  • Ito A., Hirohama M., Igarashi Y., Kondoh Y., Saito T., Osada H., and Yoshida M.
    Discovery of Spectomycin B1 as a SUMO E2 Inhibitor
  • Piotrowski J. S., Deshpande R., Andrusiak K., Saito T., Osada H., Myers C., Yoshida M., and Boone C. M.
    Linking novel bioactive compounds to their targets and pathways using high-throughput yeast chemical genomics

16th Japanese Foundation for Cancer Research International Symposium on Cancer Chemotherapy

Jan. 25th - 26th, 2012, Tokyo,
  • Kawatani M., Muroi M., and Osada H.
    Identification of novel tubulin polymerization inhibitors by proteomic profiling